Sabinsa’s LactoSpore get Canadian approval

Sabinsa’s LactoSpore get Canadian approval

Related tags Nutrition Canada Sabinsa

Health Canada has reviewed and approved Sabinsa’s shelf-stable probiotic LactoSpore ingredient for sale in Canada.

The pre-market approval means that Sabinsa’s LactoSpore Masterfile has been substantiated with the required safety profile, allowing potential customers to request a Letter of Access from Sabinsa. With that, customers can apply for a Product License Application (PLA) with the Natural and Non-Prescription Health Products Directorate (NNHPD) and obtain an NPN number for their formulations containing LactoSpore for purpose of sales in Canada as a Natural Health Product.

“Our investment in and commitment to LactoSpore runs deep,”​ said Shaheen Majeed, Sabinsa’s Marketing Director.  “Realizing in the late 1990’s the potential of this ingredient, we invested in our own dedicated manufacturing facility to ensure ample and consistent supply of material meeting our quality standards. We made it a strong candidate for inclusion in functional foods by having it GRAS affirmed.

“We have now cleared the way for customers to sell products with our LactoSpore strain in Canada. These are exciting times for this brand and there’s more to come this year.”

Emerging science for LactoSpore, which has been on the market for over 20 years, is seeing a move beyond maintaining gut health into sports nutrition, IBS and related gut health conditions, said the company. GRAS status in the Ushas allowed the ingredient to be incorporated into a variety of foods and beverages, including chocolate, gummies, candies, yogurts and soups.  

Majeed told us: "In our communication with Health Canada, they mentioned to me that this was one of the 'hottest' and most trend worthy ingredients that was being requested access to, for use in Canada. I knew then Sabinsa had to take action."​ 

Related topics Suppliers

Related news

Show more

Follow us


View more